-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/DTRggkjEPQ5-ALArTjrhKT
July 11, 2017 - disease (CVD) preven-
tion, including guidance on healthy lifestyle counseling6,7; screen-
ing and treatment … Overall, few deaths were reported, and
no differences were observed between treatment and control groups … The behavioral and clinical effects of therapeutic
lifestyle change on middle-aged adults. … Behavioral
treatment for weight gain prevention among black
women in primary care practice: a randomized … Effectiveness of primary care–relevant
treatments for obesity in adults: a systematic
evidence review
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
December 01, 2007 - of drug therapy
and adverse quality-of-life outcomes. … New evidence on the harms of
treatment of early hypertension shows that pharmacologic therapy
is associated … failure; CRF � chronic renal failure;
CVD � cardiovascular disease; DBP � diastolic blood pressure; DM � diabetes … group allocation, reports
of adverse effects of drug therapy, and quality-of-life out-
comes. … New evidence on the
harms of treatment of early hypertension shows that phar-
macologic therapy is associated
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
October 15, 2009 - Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise … Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. … Diabetes Care . 2002;25:1845-50. … Diabetes Care . 1997;20:935-42. … The San Luis Valley Diabetes Study. Circulation . 1995;91:1472-9.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
October 07, 2011 - Few studies evaluated newer therapies. … important adverse events, such as coronary heart disease, myocardial infarction, diabetes, and fractures … Not defined
6 y
73
Tumor stage NR (all were clinically localized)
Age; comorbid conditions (diabetes … Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans … Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/fbQmoAPKeBekmJ7aqmALe5
June 01, 2014 - Other reported risk factors for cognitive
impairment include cardiovascular risk factors (such as diabetes … Pharmacologic treatments approved by the U.S. … clinicians to anticipate problems
patients may have in understanding and adhering to rec-
ommended therapy … Pharmacologic treatments approved by the
U.S. … Treatment of mild to moderate dementia with several drug
therapies and nonpharmacologic interventions
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
March 01, 2016 - for wet AMD (laser photocoagulation and photodynamic therapy). … Conclusions from the 2009 USPSTF review regarding the
effectiveness of treatments vs no treatment … language
studies has little effect on conclusions of reviews of noncomplementary
and alternative therapies … Research is also needed to understand
the effectiveness of new therapies that are being investigated … f Adjusted for age; sex; race; education; smoking status; body mass index; and presence of diabetes,
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
January 01, 2017 - Trials of CPAP and other treatments have not established whether treatment
reduces mortality or improves … Trials of CPAP and other treatments have
not established whether treatment reduces mortality or improves … Improving activity
in adults with diabetes and coexisting obstructive
sleep apnea. … Randomised prospective parallel trial of therapeutic
versus subtherapeutic nasal continuous positive … Surgical vs conventional therapy for weight loss
treatment of obstructive sleep apnea:
a randomized controlled
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening-2010
January 15, 2010 - Limited evidence suggests that these improvements can be sustained over the year after treatment. … have a sizeable health impact. 5 , 6 Obese children and adolescents have an increased risk of type 2 diabetes … Multicomponent behavioral interventions and interventions that combined behavioral and pharmacologic treatments … Surgical treatments, which are reserved for morbidly obese patients who are identified without the need … Combined Pharmacologic and Behavioral Interventions
Seven trials combined pharmacologic treatments
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
May 25, 2021 - Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes … Diabetes Care . 2016;39(1):24-30. … The Treatment of Obese Pregnant women (TOP) study: a randomized controlled trial of the effect of physical … Diabetes Care . 2011;34(12):2502-2507. doi:10.2337/dc11-1150 81. … Randomized controlled trial of home-based lifestyle therapy on postpartum weight in underserved women
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertensive-disorders-pregnancy-screening
September 19, 2023 - a previous adverse pregnancy outcome, and maternal comorbid conditions (including type 1 or type 2 diabetes … prior to pregnancy, gestational diabetes, chronic hypertension, kidney disease, and autoimmune diseases … or mortality. 1
Race and ethnicity may influence the likelihood of patients receiving recommended treatments … nulliparity, age, family history, previous preeclampsia, body mass index >30 kg/m 2 , twin pregnancy, or diabetes … The USPSTF previously found adequate evidence that the well-established treatments of preeclampsia result
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/8uE22djVfm8hF8wNg7wWYn
May 01, 2021 - with iron therapy … with iron
therapy.1 To establish the presence of iron deficiency or iron defi-
ciency anemia, levels … variability,
limiting interpretation of this evidence.1,17 In 4 trials reporting ma-
ternal gestational diabetes … and uncertain.1,17 Two trials24,26 (n = 2214) found no dif-
ferences in rates of maternal gestational diabetes … Iron
supplement in pregnancy and development of
gestational diabetes—a randomised
placebo-controlled
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LNtA2SDWjpsDwjXvsH4F5m
April 17, 2023 - • The USPSTF previously found adequate evidence that the well-established treatments of preeclampsia … a previous adverse pregnancy outcome, and maternal
comorbid conditions (including type 1 or type 2 diabetes … prior to preg-
nancy, gestational diabetes, chronic hypertension, kidney disease,
and autoimmune diseases … or mortality.1
Race and ethnicity may influence the likelihood of patients re-
ceiving recommended treatments … nulliparity, age, family his-
tory, previous preeclampsia, body mass index >30 kg/m2, twin preg-
nancy, or diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/mHfCYrWoEdSr95bCUSfSEz
September 21, 2021 - Meta-analysis of Trials: Mean Gestational Weight Gain
–8 –6 –2 420 6–4
Mean difference
(95% CI)
Favors
treatment … Favors
control
Treatment
Mean gestational weight gain
No. … Diabetes Care. 2016;39(1):24-30. … The
Treatment of Obese Pregnant women (TOP) study:
a randomized controlled trial of the effect of
physical … Randomized controlled trial of home-based lifestyle
therapy on postpartum weight in underserved
women
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
March 01, 2009 - Treatment
The optimum dose of aspirin for preventing cardiovas-
cular disease events is not known. … and no contraindications to aspirin therapy (11). … among persons whose risk is
sufficiently high for the benefits to outweigh the risks as-
sociated with treatment … prevention of
stroke in women whose risk is sufficiently high for the
benefits to outweigh the harms of treatment … ment from the American Heart Association and the American Diabetes Associa-
tion.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan6/high-blood-pressure-in-adults-screening-monitoring-october-2015
September 15, 2013 - for confirmation (or no confirmation) of the diagnosis of hypertension at a subsequent encounter, and treatment … *Elevated blood pressure is defined as the threshold for pharmacologic treatment. … underlying causes of high blood pressure, and highly selected groups of patients (e.g., patients with diabetes … Analytic Framework, elevated blood pressure is now generally defined as the threshold for pharmacologic treatment … Additional comments addressed issues already covered by the Key Questions, treatment questions that this
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
March 02, 2020 - Sustained virologic response after antiviral therapy was consistently associated with decreased risk … Direct-acting antiviral regimens are associated with fewer harms than older interferon-containing therapies … for headache and were also lower when compared with rates reported for older interferon-containing therapies … function, and extrahepatic effects of HCV infection (eg, renal function, cardiovascular effects, or diabetes … Currently recommended DAA regimens are associated with fewer harms than older interferon-containing therapies
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Pharmacologic treatments for osteoporosis inhibit osteoclastic bone resorption (antiresorptive agents … Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. … TBS (trabecular bone score) and diabetes-related fracture risk. … disease, i living in a nursing home, i COPD, i cancer, i lupus, i anticonvulsant use, i type 1 diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/r9MoffF79edExY5m2V_koD
May 01, 2021 - For the screening framework, studies compared screening with
no screening or treatment with no treatment … improvement in newborn and peripartum outcomesa
1 Observational
study (n = 20 690)
Response to iron therapy … Treatments for iron-deficiency anaemia in
pregnancy. … The impact of response
to iron therapy on maternal and neonatal outcomes
among pregnant women with anemia … Diabetes Res Clin Pract. 2021;176:108853. doi:10.
1016/j.diabres.2021.108853
53.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
January 01, 2012 - Screening and Treatment for Depression in Children
3. … of diagnosis and treatment on quality of life.
4. … However, the USPSTF found a lack of relevant studies on whether drug therapies reduce the risk
for fractures … D
Hormone Replacement Therapy: Preventive Medication for Postmenopausal Women
The USPSTF recommends … D
Hormone Replacement Therapy: Preventive Medication for Postmenopausal Women Who Have Had a Hysterectomy
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
January 14, 2025 - Diabetes Study phase I. … Diabetes Care . 2019;42(1):102-109. doi:10.2337/dc18-1486 67. … Optimal fracture prediction thresholds for therapy onset, established from FRAX and Garvan algorithms … TBS (trabecular bone score) and diabetes-related fracture risk. … Fracture risk and zoledronic acid therapy in men with osteoporosis.